Rana Mckay, MD
Financial relationships
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Non-urology Healthcare Related)Ineligible company:BayerMitigation strategy:Peer reviewDate reviewed:06/23/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (General Urology)Ineligible company:NovartisMitigation strategy:Peer reviewDate reviewed:06/23/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:ExelixisMitigation strategy:Peer reviewDate reviewed:06/23/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (General Urology)Ineligible company:JanssenMitigation strategy:Peer reviewDate reviewed:06/23/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Non-urology Healthcare Related)Ineligible company:BMSMitigation strategy:Peer reviewDate reviewed:06/23/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Non-urology Healthcare Related)Ineligible company:TempusMitigation strategy:Peer reviewDate reviewed:06/23/2023
-
Attribution:SelfType of financial relationship:Scientific Study or Trial (Oncology)Ineligible company:AveoMitigation strategy:Peer reviewDate reviewed:06/23/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:CalitheraMitigation strategy:Peer reviewDate reviewed:06/23/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:TelixMitigation strategy:Peer reviewDate reviewed:06/23/2023
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:SeaGenMitigation strategy:Peer reviewDate reviewed:06/23/2023